XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Jan. 28, 2023   524,160,209      
Balance at beginning of period at Jan. 28, 2023 $ 938,019 $ 30 $ 2,107,013 $ (652) $ (1,168,372)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   14,308,592      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 2 $ 2      
Issuance of common stock in connection with equity compensation plans (in shares)   1,700,016      
Issuance of common stock in connection with equity compensation plans 13,391   13,391    
Vesting of early exercised stock options 25   25    
Stock-based compensation expense 173,636   173,636    
Other comprehensive loss (787)     (787)  
Net loss (173,355)       (173,355)
Balance at end of period (in shares) at Oct. 28, 2023   540,168,817      
Balance at end of period at Oct. 28, 2023 950,931 $ 32 2,294,065 (1,439) (1,341,727)
Balance at beginning of period (in shares) at Jul. 29, 2023   534,917,397      
Balance at beginning of period at Jul. 29, 2023 936,367 $ 31 2,233,533 (1,001) (1,296,196)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   5,063,177      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   188,243      
Issuance of common stock in connection with equity compensation plans 265   265    
Stock-based compensation expense 60,267   60,267    
Other comprehensive loss (438)     (438)  
Net loss (45,531)       (45,531)
Balance at end of period (in shares) at Oct. 28, 2023   540,168,817      
Balance at end of period at Oct. 28, 2023 950,931 $ 32 2,294,065 (1,439) (1,341,727)
Balance at beginning of period (in shares) at Feb. 03, 2024   545,973,529      
Balance at beginning of period at Feb. 03, 2024 915,147 $ 32 2,368,597 1,616 (1,455,098)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   14,077,918      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 2 $ 2      
Issuance of common stock in connection with equity compensation plans (in shares)   1,146,308      
Issuance of common stock in connection with equity compensation plans 16,959   16,959    
Shares withheld related to net share settlement of RSUs (in shares)   (140)      
Shares withheld related to net share settlement of RSUs (7)   (7)    
Stock-based compensation expense 212,355   212,355    
Other comprehensive loss (1,616)     (1,616)  
Net loss (143,705)       (143,705)
Balance at end of period (in shares) at Nov. 02, 2024   561,197,615      
Balance at end of period at Nov. 02, 2024 999,135 $ 34 2,597,904 0 (1,598,803)
Balance at beginning of period (in shares) at Aug. 03, 2024   556,361,204      
Balance at beginning of period at Aug. 03, 2024 964,683 $ 33 2,524,042 1,605 (1,560,997)
Stockholders' Equity (Deficit)          
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)   4,617,756      
Issuance of common stock for vesting of restricted stock units (“RSUs”) 1 $ 1      
Issuance of common stock in connection with equity compensation plans (in shares)   218,795      
Issuance of common stock in connection with equity compensation plans 36   36    
Shares withheld related to net share settlement of RSUs (in shares)   (140)      
Shares withheld related to net share settlement of RSUs (7)   (7)    
Stock-based compensation expense 73,833   73,833    
Other comprehensive loss (1,605)     (1,605)  
Net loss (37,806)       (37,806)
Balance at end of period (in shares) at Nov. 02, 2024   561,197,615      
Balance at end of period at Nov. 02, 2024 $ 999,135 $ 34 $ 2,597,904 $ 0 $ (1,598,803)